You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

PREMPRO (PREMARIN;CYCRIN) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Prempro (premarin;cycrin), and when can generic versions of Prempro (premarin;cycrin) launch?

Prempro (premarin;cycrin) is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in PREMPRO (PREMARIN;CYCRIN) is estrogens, conjugated; medroxyprogesterone acetate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, conjugated; medroxyprogesterone acetate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PREMPRO (PREMARIN;CYCRIN)?
  • What are the global sales for PREMPRO (PREMARIN;CYCRIN)?
  • What is Average Wholesale Price for PREMPRO (PREMARIN;CYCRIN)?
Summary for PREMPRO (PREMARIN;CYCRIN)
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 72
DailyMed Link:PREMPRO (PREMARIN;CYCRIN) at DailyMed
Drug patent expirations by year for PREMPRO (PREMARIN;CYCRIN)

US Patents and Regulatory Information for PREMPRO (PREMARIN;CYCRIN)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc PREMPRO (PREMARIN;CYCRIN) estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020303-001 Dec 30, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PREMPRO (PREMARIN;CYCRIN)

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc PREMPRO (PREMARIN;CYCRIN) estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020303-001 Dec 30, 1994 ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms Inc PREMPRO (PREMARIN;CYCRIN) estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020303-001 Dec 30, 1994 ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms Inc PREMPRO (PREMARIN;CYCRIN) estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020303-001 Dec 30, 1994 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for PREMPRO (PREMARIN;CYCRIN)

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0136011 91096 Luxembourg ⤷  Sign Up 91096, EXPIRES: 20090802
0136011 C00136011/03 Switzerland ⤷  Sign Up PRODUCT NMAE: ESTRADIOL UND MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: IKS 55288 20000417
0136011 99C0003 Belgium ⤷  Sign Up PRODUCT NAME: ESTRADIOL AND NORETHISTERONE; FIRST REGISTRATION NO/DATE: 403 IS 106 F3 19980928; FIRST REGISTRATION: SE 14007 19980306
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.